DYNAVAX TECHNOLOGIES CORP (DVAX)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Total revenues | 95,442 | 68,164 | 80,630 | |
Selling, general and administrative | 50,359 | 47,678 | 43,061 | |
Research and development | 16,619 | 19,377 | 14,403 | |
Cost of sales - product | 14,035 | 13,769 | 13,084 | |
Bad debt expense | - | 10,970 | - | |
Total operating expenses | 81,013 | 91,794 | 70,548 | |
Income (loss) from operations | 14,429 | -23,630 | 10,082 | |
Interest income | 6,798 | 7,739 | 9,382 | |
Interest expense | 1,641 | 1,692 | 1,699 | |
Loss on debt extinguishment | - | -82,095 | - | |
Sublease income | 2,226 | 2,226 | 2,205 | |
Other (loss) income | -596 | -423 | -152 | |
Net income (loss) before income taxes | 21,216 | -97,875 | 19,818 | |
Provision for income taxes | 2,495 | -1,776 | 2,224 | |
Net income (loss) | 18,721 | -96,099 | 17,594 | |
Basic (in shares) | 119,317,000 | 124,871,000 | 131,133,000 | |
Basic (in usd per share) | 0.16 | -0.77 | 0.13 | |
Diluted (in shares) | 138,356,000 | 124,871,000 | 154,807,000 | |
Diluted (in usd per share) | 0.14 | -0.77 | 0.12 |